Celgene Corp (CELG) 106.45 $CELG
Final Glance: Biotechnology companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Ride The Smart-Money Coattails: Use IBD's Funds Pages
at Investor's Business Daily - Fri Nov 07, 3:10PM CST
Selecting stocks that have superior profit and sales growth is not the sole key to success in the market. Neither is simply buying stocks with outstanding price strength. Before you invest in a stock, make sure that it also is a favorite among the...
AGN: 196.00 (-1.40), HCA: 65.75 (-3.22), BIDU: 236.54 (-0.36), ZBRA: 72.59 (-1.29), SWKS: 59.88 (-2.26), ALK: 55.14 (-0.26), CELG: 106.45 (-0.69)
Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig
Todd Campbell, The Motley Fool - Motley Fool - Fri Nov 07, 12:42PM CST
Source: Pharmacyclics Peak sales forecasts for Pharmacyclics' Imbruvica are estimated north of $3 billion, but investors had reason for pause last quarter when competitor Gilead Sciences launched Zydelig for the same indication. ...
JNJ: 108.20 (-0.81), PCYC: 133.49 (-3.63), GILD: 106.45 (-0.49), AZN: 72.88 (+0.03), GSK: 44.91 (+0.16), BMY: 58.32 (-0.14), CELG: 106.45 (-0.69)
Midday Glance: Biotechnology companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Early Glance: Biotechnology companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Data from More Than 160 Abstracts Highlighting Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH)
Business Wire - Thu Nov 06, 4:30PM CST
Celgene Corporation (NASDAQ:CELG) today announced that data from more than 160 abstracts, including 39 oral presentations, evaluating Celgene investigational products and investigational uses of marketed products will be presented at the 56th American Society of Hematology Annual Meeting between Dec. 6-9 in San Francisco, Calif.
CELG: 106.45 (-0.69), CELGZ: 3.24 (-0.04)
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 91.06 (-3.49), RNA: 12.14 (+0.08), AGIO: 72.06 (-11.03), CELG: 106.45 (-0.69)
Why Celgene Corporation Stock Rocketed 13% Higher in October
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 06, 7:07AM CST
CELG data by YCharts What: Shares of biopharmaceutical giant Celgene rocketed higher by 13% in October, based on data provided by S&P Capital IQ , after the company reported better-than-expected third-quarter earnings results and...
CELG: 106.45 (-0.69)
Uptrend Call Working As Celgene Stock Rises 11.2% (CELG)
Comtex SmarTrend(R) - Wed Nov 05, 5:19PM CST
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on October 21st, 2014 at $94.56. In approximately 2 weeks, Celgene has returned 11.20% as of today's recent price of $105.15.
CELG: 106.45 (-0.69)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), ORLY: 179.00 (-0.61), AFSI: 49.89 (-0.58), CELG: 106.45 (-0.69)
Critical Alerts For Alibaba, Bloomin' Brands, VoxelJet, 51job and Celgene Released By InvestorsObserver
PR Newswire - Wed Nov 05, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for BABA, BLMN, VJET, JOBS and CELG.
JOBS: 34.06 (+1.66), VJET: 12.33 (-0.61), BLMN: 21.69 (-0.18), CELG: 106.45 (-0.69), BABA: 114.56 (+2.99)
5 Things Celgene Corporation's Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Wed Nov 05, 6:51AM CST
Source: U.S. Department of Agriculture via Flickr . Following another successful quarterly report, investors and shareholders of Celgene have to be wondering if anything can stop this stock from heading higher . For the quarter, Celgene...
OMED: 20.19 (-0.02), AMGN: 160.25 (-0.10), ABBV: 61.50 (-1.21), CELG: 106.45 (-0.69)
These 5 Drugmakers' Earnings Excelled This Quarter
at Investor's Business Daily - Tue Nov 04, 7:14PM CST
Big pharma firms such as Alexion Pharmaceuticals and Biogen Idec continue to outperform the market as they develop and market new treatments to treat long-time targets such as Alzheimer's as well as rare illnesses. Today's Screen Of The Day is Big...
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), VRX: 126.11 (-2.66), ACT: 245.91 (-4.47), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), CELG: 106.45 (-0.69)
Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 47.14 (+1.13), MNST: 108.39 (+7.91), SWKS: 59.88 (-2.26), GMCR: 152.90 (-0.16), ILMN: 186.35 (-3.52), WSM: 65.88 (-0.05), NXPI: 73.54 (+0.07), CELG: 106.45 (-0.69), HAIN: 107.68 (-0.16), AGN: 196.00 (-1.40), CNC: 91.72 (-1.84), V: 252.43 (+2.34), CALM: 43.03 (-0.09), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), LOW: 57.69 (+0.12), ULTA: 121.75 (-0.33), MA: 84.80 (-0.95), AVGO: 85.04 (-2.59), PETM: 72.54 (+0.90)
Next Support Level for Celgene (CELG) is $105.49
Comtex SmarTrend(R) - Tue Nov 04, 12:59PM CST
Shares of Celgene (NASDAQ:CELG) have bearishly opened below the pivot of $107.01 today and have reached the first support level of $106.45. Should the shares continue to fall, the support pivots of $105.49 and $103.97 will be of interest.
CELG: 106.45 (-0.69)
Final Glance: Biotechnology companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Ride The Smart-Money Coattails: Use IBD's Funds Pages
at Investor's Business Daily - Fri Nov 07, 3:10PM CST
Selecting stocks that have superior profit and sales growth is not the sole key to success in the market. Neither is simply buying stocks with outstanding price strength. Before you invest in a stock, make sure that it also is a favorite among the...
AGN: 196.00 (-1.40), HCA: 65.75 (-3.22), BIDU: 236.54 (-0.36), ZBRA: 72.59 (-1.29), SWKS: 59.88 (-2.26), ALK: 55.14 (-0.26), CELG: 106.45 (-0.69)
Pharmacyclics, Inc.'s Imbruvica Holds Its Own Against Gilead Sciences, Inc.'s Zydelig
Todd Campbell, The Motley Fool - Motley Fool - Fri Nov 07, 12:42PM CST
Source: Pharmacyclics Peak sales forecasts for Pharmacyclics' Imbruvica are estimated north of $3 billion, but investors had reason for pause last quarter when competitor Gilead Sciences launched Zydelig for the same indication. ...
JNJ: 108.20 (-0.81), PCYC: 133.49 (-3.63), GILD: 106.45 (-0.49), AZN: 72.88 (+0.03), GSK: 44.91 (+0.16), BMY: 58.32 (-0.14), CELG: 106.45 (-0.69)
Midday Glance: Biotechnology companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Early Glance: Biotechnology companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 106.45 (-0.49), AMGN: 160.25 (-0.10), CELG: 106.45 (-0.69)
Data from More Than 160 Abstracts Highlighting Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH)
Business Wire - Thu Nov 06, 4:30PM CST
Celgene Corporation (NASDAQ:CELG) today announced that data from more than 160 abstracts, including 39 oral presentations, evaluating Celgene investigational products and investigational uses of marketed products will be presented at the 56th American Society of Hematology Annual Meeting between Dec. 6-9 in San Francisco, Calif.
CELG: 106.45 (-0.69), CELGZ: 3.24 (-0.04)
Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 91.06 (-3.49), RNA: 12.14 (+0.08), AGIO: 72.06 (-11.03), CELG: 106.45 (-0.69)
Why Celgene Corporation Stock Rocketed 13% Higher in October
Sean Williams, The Motley Fool - Motley Fool - Thu Nov 06, 7:07AM CST
CELG data by YCharts What: Shares of biopharmaceutical giant Celgene rocketed higher by 13% in October, based on data provided by S&P Capital IQ , after the company reported better-than-expected third-quarter earnings results and...
CELG: 106.45 (-0.69)
Uptrend Call Working As Celgene Stock Rises 11.2% (CELG)
Comtex SmarTrend(R) - Wed Nov 05, 5:19PM CST
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on October 21st, 2014 at $94.56. In approximately 2 weeks, Celgene has returned 11.20% as of today's recent price of $105.15.
CELG: 106.45 (-0.69)
Let Major Indexes Dictate Buy, Sell Decisions
at Investor's Business Daily - Wed Nov 05, 5:01PM CST
The S&P 500 and Nasdaq composite serve as guideposts to the market's health. Ignore them at your own peril. Every day, IBD analyzes the action of these major stock averages to determine whether the market is in an uptrend (healthy) or a correction...
LCI: 50.17 (-0.82), AKRX: 36.59 (-1.29), ORLY: 179.00 (-0.61), AFSI: 49.89 (-0.58), CELG: 106.45 (-0.69)
Critical Alerts For Alibaba, Bloomin' Brands, VoxelJet, 51job and Celgene Released By InvestorsObserver
PR Newswire - Wed Nov 05, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for BABA, BLMN, VJET, JOBS and CELG.
JOBS: 34.06 (+1.66), VJET: 12.33 (-0.61), BLMN: 21.69 (-0.18), CELG: 106.45 (-0.69), BABA: 114.56 (+2.99)
5 Things Celgene Corporation's Management Wants You to Know
Sean Williams, The Motley Fool - Motley Fool - Wed Nov 05, 6:51AM CST
Source: U.S. Department of Agriculture via Flickr . Following another successful quarterly report, investors and shareholders of Celgene have to be wondering if anything can stop this stock from heading higher . For the quarter, Celgene...
OMED: 20.19 (-0.02), AMGN: 160.25 (-0.10), ABBV: 61.50 (-1.21), CELG: 106.45 (-0.69)
These 5 Drugmakers' Earnings Excelled This Quarter
at Investor's Business Daily - Tue Nov 04, 7:14PM CST
Big pharma firms such as Alexion Pharmaceuticals and Biogen Idec continue to outperform the market as they develop and market new treatments to treat long-time targets such as Alzheimer's as well as rare illnesses. Today's Screen Of The Day is Big...
AGN: 196.00 (-1.40), BIIB: 320.75 (-2.72), VRX: 126.11 (-2.66), ACT: 245.91 (-4.47), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), CELG: 106.45 (-0.69)
Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 47.14 (+1.13), MNST: 108.39 (+7.91), SWKS: 59.88 (-2.26), GMCR: 152.90 (-0.16), ILMN: 186.35 (-3.52), WSM: 65.88 (-0.05), NXPI: 73.54 (+0.07), CELG: 106.45 (-0.69), HAIN: 107.68 (-0.16), AGN: 196.00 (-1.40), CNC: 91.72 (-1.84), V: 252.43 (+2.34), CALM: 43.03 (-0.09), JAZZ: 170.80 (-1.57), ALXN: 193.81 (+0.67), LOW: 57.69 (+0.12), ULTA: 121.75 (-0.33), MA: 84.80 (-0.95), AVGO: 85.04 (-2.59), PETM: 72.54 (+0.90)
Next Support Level for Celgene (CELG) is $105.49
Comtex SmarTrend(R) - Tue Nov 04, 12:59PM CST
Shares of Celgene (NASDAQ:CELG) have bearishly opened below the pivot of $107.01 today and have reached the first support level of $106.45. Should the shares continue to fall, the support pivots of $105.49 and $103.97 will be of interest.
CELG: 106.45 (-0.69)
